FR2857872B1 - USE OF NONI DURING BUCCO DENTAL PATHOLOGY, PARTICULARLY TO COMBAT ISSUES OF ASIALIA AND HYPOSIALISM - Google Patents

USE OF NONI DURING BUCCO DENTAL PATHOLOGY, PARTICULARLY TO COMBAT ISSUES OF ASIALIA AND HYPOSIALISM

Info

Publication number
FR2857872B1
FR2857872B1 FR0309130A FR0309130A FR2857872B1 FR 2857872 B1 FR2857872 B1 FR 2857872B1 FR 0309130 A FR0309130 A FR 0309130A FR 0309130 A FR0309130 A FR 0309130A FR 2857872 B1 FR2857872 B1 FR 2857872B1
Authority
FR
France
Prior art keywords
hyposialism
asialia
bucco
noni
during
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0309130A
Other languages
French (fr)
Other versions
FR2857872A1 (en
Inventor
Jean Claude Vezin
Arros Gerard D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to FR0309130A priority Critical patent/FR2857872B1/en
Priority to PCT/FR2004/001975 priority patent/WO2005018655A1/en
Publication of FR2857872A1 publication Critical patent/FR2857872A1/en
Application granted granted Critical
Publication of FR2857872B1 publication Critical patent/FR2857872B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/746—Morinda
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
FR0309130A 2003-07-25 2003-07-25 USE OF NONI DURING BUCCO DENTAL PATHOLOGY, PARTICULARLY TO COMBAT ISSUES OF ASIALIA AND HYPOSIALISM Expired - Fee Related FR2857872B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0309130A FR2857872B1 (en) 2003-07-25 2003-07-25 USE OF NONI DURING BUCCO DENTAL PATHOLOGY, PARTICULARLY TO COMBAT ISSUES OF ASIALIA AND HYPOSIALISM
PCT/FR2004/001975 WO2005018655A1 (en) 2003-07-25 2004-07-23 Use of noni in relation to oral pathologies, for example, in order to combat problems associated with asialia and hyposialia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0309130A FR2857872B1 (en) 2003-07-25 2003-07-25 USE OF NONI DURING BUCCO DENTAL PATHOLOGY, PARTICULARLY TO COMBAT ISSUES OF ASIALIA AND HYPOSIALISM

Publications (2)

Publication Number Publication Date
FR2857872A1 FR2857872A1 (en) 2005-01-28
FR2857872B1 true FR2857872B1 (en) 2007-11-02

Family

ID=33561106

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0309130A Expired - Fee Related FR2857872B1 (en) 2003-07-25 2003-07-25 USE OF NONI DURING BUCCO DENTAL PATHOLOGY, PARTICULARLY TO COMBAT ISSUES OF ASIALIA AND HYPOSIALISM

Country Status (2)

Country Link
FR (1) FR2857872B1 (en)
WO (1) WO2005018655A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050084551A1 (en) * 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
KR101123146B1 (en) 2010-07-19 2012-03-20 박용억 Method for preparing detergent composition comprising morinda citriforia extract

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US20030091666A1 (en) * 2001-11-14 2003-05-15 Howard Murad Methods and compositions for treating dermatological disorders with Morinda citrifolia

Also Published As

Publication number Publication date
WO2005018655A1 (en) 2005-03-03
FR2857872A1 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
DK1282391T3 (en) Dental care with high cleaning effect
ATE258918T1 (en) CRYSTAL FORM ALPHA OF PERINDOPRIL-TERT-BUTYLAMINE SALT
DK1381367T3 (en) Oral aripiprazole solution
DE60219450D1 (en) SKIN-FRIENDLY HOOK CLOSURE
ID30590A (en) ONCE USE SHORT TYPE OF SHORT-PANTS
IL171501A (en) Genetically modified dermal micro-organs and use of the same
DE60020795D1 (en) Real-time modeling of the behavior of human vision systems
EP1683784A4 (en) Diimonium salt compound and use thereof
DE69909135D1 (en) ORAL PREPARATION FOR FIGHT AGAINST MOUTH
CY2009013I1 (en) NOVEL USE OF A PEPTIDE CLASS COMPOUND FOR THE TREATMENT OF NON-NEUROPATHIC INFLAMMATORY PAIN
DE602004022200D1 (en) ORAL AND BODY CARE COMPOSITIONS AND METHODS
NO20023743L (en) Filtering face mask with headband attachment
FR13C0044I2 (en) USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF CANINE EPILEPSY
DK1638589T3 (en) Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
EE200300226A (en) Inhalation of nitric oxide
GB2387916B (en) Sphygmogram measurement involving calculation of blood flow rate
FR2834459B1 (en) MICROBICIDE AGENT AND COSMETIC TREATMENT COMPOSITION CONTAINING THE SAME
DE60138253D1 (en) DENTAL DIET TO REDUCE THE TOOTH
IS6967A (en) New cyano-linked dihydropyrimidine compounds and their use in the treatment of diseases
HUP0401392A3 (en) Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response
DK1670482T4 (en) USE OF CICLESONIDE IN THE TREATMENT OF RESPIRATORY DISEASES
FR2857872B1 (en) USE OF NONI DURING BUCCO DENTAL PATHOLOGY, PARTICULARLY TO COMBAT ISSUES OF ASIALIA AND HYPOSIALISM
FI20011069A0 (en) New methods of use for drafting of reed construction
NO20025964L (en) New interferon for the treatment of multiple sclerosis
AU2002365281A1 (en) Thiochromenones used to combat painful conditions and neurodegenerative diseases

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20200306